Abbisko Therapeutics
Shanghai
About Abbisko Therapeutics
Abbisko Therapeutics is a drug company dedicated to innovative drug research and development. The company is founded by a group of seasoned drug hunters with rich research and managerial experience in top pharmaceutical companies globally and in China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $50K – $100K
- Total funding: $263.0M
- Funding stage: IPO
- Last round: Series D (Jan 2021)
- Ticker: sehk:2256
- Website: abbisko.com
- Phone: (+86) 021-68911058
Industries & Categories
Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/abbisko-therapeutics-62955 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.